0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Covishield, the Oxford-AstraZeneca vaccine produced for India has shown an interim vaccine efficacy of 81 percent in preventing the virus. Bharat Biotech's Covaxin is 80 percent effective.
Share this article
If you liked this article share it with your friends.they will thank you later